Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

Auteurs

E. Kaczmarek, C. Saint-Martin, J.-Y. Pierga, E. Brain, R. Rouzier, A. Savignoni, E. Mouret-Fourme, V. Dieras, I. Piot, C. Dubot, M. Carton, F. Lerebours